Stada to commercialize Rowiren in Nordic region
Ähnliche Neuigkeiten
Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health
Medis has signed a long-term agreement with Salix for the commercialization of a new and innovative digestive health product in 11 different countries across...
Lesen Sie mehr
BIAL and Medis entered into a partnership for innovative medicines for the central nervous system
BIAL and Medis announce that they have entered into an exclusive partner-ship on two BIAL's proprietary medicines eslicarbazepine acetate and opicapone.
Lesen Sie mehr
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Lesen Sie mehr